DK0816356T3 - 1-(2-(1-Piperidinyl)-1-ethyl)-1,3-dihydro-2H-benzimidazolderivater og deres farmaceutiske anvendelse - Google Patents

1-(2-(1-Piperidinyl)-1-ethyl)-1,3-dihydro-2H-benzimidazolderivater og deres farmaceutiske anvendelse

Info

Publication number
DK0816356T3
DK0816356T3 DK97304485T DK97304485T DK0816356T3 DK 0816356 T3 DK0816356 T3 DK 0816356T3 DK 97304485 T DK97304485 T DK 97304485T DK 97304485 T DK97304485 T DK 97304485T DK 0816356 T3 DK0816356 T3 DK 0816356T3
Authority
DK
Denmark
Prior art keywords
piperidinyl
dihydro
ethyl
pharmaceutical use
alkyl
Prior art date
Application number
DK97304485T
Other languages
English (en)
Inventor
Peter Thaddeus Gallagher
Martin Victor Miles
William Martin Owton
Colin William Smith
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0816356T3 publication Critical patent/DK0816356T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97304485T 1996-06-26 1997-06-25 1-(2-(1-Piperidinyl)-1-ethyl)-1,3-dihydro-2H-benzimidazolderivater og deres farmaceutiske anvendelse DK0816356T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9613423.4A GB9613423D0 (en) 1996-06-26 1996-06-26 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
DK0816356T3 true DK0816356T3 (da) 2001-01-02

Family

ID=10795937

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97304485T DK0816356T3 (da) 1996-06-26 1997-06-25 1-(2-(1-Piperidinyl)-1-ethyl)-1,3-dihydro-2H-benzimidazolderivater og deres farmaceutiske anvendelse

Country Status (11)

Country Link
US (1) US6075039A (da)
EP (1) EP0816356B1 (da)
JP (1) JPH1059962A (da)
AT (1) ATE197299T1 (da)
CA (1) CA2208652A1 (da)
DE (1) DE69703413T2 (da)
DK (1) DK0816356T3 (da)
ES (1) ES2151706T3 (da)
GB (1) GB9613423D0 (da)
GR (1) GR3035251T3 (da)
PT (1) PT816356E (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521623B1 (en) 2000-09-19 2003-02-18 Boehringer Ingelheim Pharma Kg N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
WO2002024661A2 (en) * 2000-09-19 2002-03-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
JPWO2002060878A1 (ja) * 2001-01-30 2004-06-03 住友製薬株式会社 ベンズイミダゾリジノン誘導体
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
JP5793828B2 (ja) 2006-08-14 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング フリバンセリンの製剤及びその製造方法
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
EP2056797A2 (en) 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH Controlled release system and method for manufacturing the same
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
CA3139026A1 (en) * 2019-05-31 2020-12-03 Chang Sik Lee 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE659364A (da) * 1964-02-05
US4035369A (en) * 1975-10-08 1977-07-12 Janssen Pharmaceutica N.V. 1-Benzazolylalkyl-4-substituted-piperidines
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
EP0181793B1 (fr) * 1984-10-16 1988-07-27 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
JPH09505029A (ja) * 1993-07-19 1997-05-20 藤沢薬品工業株式会社 ドパミン受容体作動薬、５−ＨＴ受容体拮抗薬あるいはα▲下１▼受容体拮抗薬として有用なベンズイミダゾール誘導体
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
GB9613423D0 (en) 1996-08-28
GR3035251T3 (en) 2001-04-30
ATE197299T1 (de) 2000-11-15
CA2208652A1 (en) 1997-12-26
DE69703413T2 (de) 2001-03-15
EP0816356A1 (en) 1998-01-07
US6075039A (en) 2000-06-13
ES2151706T3 (es) 2001-01-01
PT816356E (pt) 2001-04-30
JPH1059962A (ja) 1998-03-03
DE69703413D1 (de) 2000-12-07
EP0816356B1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
DK0816356T3 (da) 1-(2-(1-Piperidinyl)-1-ethyl)-1,3-dihydro-2H-benzimidazolderivater og deres farmaceutiske anvendelse
DK0804421T3 (da) 2-((Dihydro)pyrazolyl-3'-oxymethylen)-anilider som skadedyrsbekæmpelsesmidler og fungicider
DK0769010T3 (da) 2-[1',2',4'-triazol-3'-yloxymethylen]-anilider og deres anvendelse som pesticider
ATE361748T1 (de) 1-(4-sulfamylphenyl)-3-trifluormethyl-5-aryl-2- pyrazoline als cyclooxygenase-2 inhibitoren
GB9801690D0 (en) Therapeutic agents
DK426889D0 (da) N-substituerede 2-(phenyl eller bicyclo (2.2.1)hept-2-yl)oxynicotinamid-forbindelser, saadanne forbindelser til terapeutisk anvendelse og deres anvendelse til fremstilling af laegemidler til behandling af depression
DE69527072T2 (de) Endothelin antagoniste
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
MY128773A (en) Substituted phenyl derivatives
NO305174B1 (no) Heterocykliske forbindelser
DE69717970D1 (de) Chinolin carbonsaure-derivate und ihre salze
DE60100873D1 (de) Eine kristallmodifikation von Celecoxib
ID18181A (id) Senyawa-senyawa baru
AUPP150098A0 (en) Benzamide derivatives
ATE240321T1 (de) 4- (thien-3-yl)methyl) imidazolderivate mit alpha2-adrenoceptor agonistischer aktivität
HUP0002961A2 (hu) Szinergetikus fungicid hatóanyag-keverék és alkalmazása
DK0630367T3 (da) Hidtil ukendte arylindazoler og deres anvendelse som herbicider
NO973441D0 (no) Substituerte fenylforbindelser som endotelinantagonister
ATE359993T1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
WO2000020399A3 (de) Verwendung von substituierten 5-hydroxypyrazolen, neue 5-hydroxypyrazole, verfahren zu deren herstellung, sowie sie enthaltende mittel
NO20011805D0 (no) Estere av (+)-<alfa>-(3,2-dimetoksyfenyl)-1-((2-(4- fluorfenyl)etyl)-4-piperidinmetanol) og deres anvendelse somprodrugs for 5HT2A-reseptorantagonist MDL 110.907
AU2001290743A1 (en) Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide
MX9204939A (es) Inhibidores 5-bis-aminometilen-1,3-dioxan-4,6-diona n,n',n'-trisubstituidas, de la acil coenzima a: colesterol-aciltransferasa.
DE60142063D1 (de) (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propion säureisopropylester, dessen herstellung und dessen verwendung
ID18481A (id) 2-(3,5-difluorofenil)-3-(4-metilsulfonil)fenil)-2-siklopenten-1-on yang berguna sebagai inhibitor cox-2